CD40LG and myeloid sarcoma: When ETX immunoreactivity was compared between MS patients and HCs after gender stratification, a strong and highly significant increase in ETX-specific IgM response was detected in women with MS as compared to control women, whereas no difference was detected in men (Figure 2C).